Načítá se...
CAR-T Cell Therapy in Diffuse Large B Cell Lymphoma: Hype and Hope
Patients with non-Hodgkin lymphomas (NHLs) resistant to standard therapies have a dismal prognosis. The outcome is even poorer in patients relapsing after autologous stem cell transplantation. Most of these patients do not qualify for an allogeneic hematopoietic cell transplantation (HCT) due to ref...
Uloženo v:
| Vydáno v: | Hemasphere |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer Health
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6746029/ https://ncbi.nlm.nih.gov/pubmed/31723824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000185 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|